Terns Pharmaceuticals Inc (TERN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TERN Annual Balance Sheets →
A period-by-period view of the balance sheet from Terns Pharmaceuticals Inc to Dec 31 2024 helps clarify how Dec 31 2025's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024)
Assets
Cash & cash equivalent524.75
Marketable Securities, Current SH494.24
Cash & Short-term Investments1,018.00
Prepaid Expense And Other Assets Current5.21
Total Current Assets1,024.19
Equipment/Property/Plant Net0.05
Other Assets, Noncurrent0.84
Total Assets1,025.08
Liabilities
Accounts Payable, Current AC1.72
Other Liabilities, Current14.69
Total Current Liabilities16.41
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent AC11.70
Other liabilities, Noncurrent0.45
Accrued Expenses And Other Current Liabilities14.22
Total Liabilities18.55
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,523.94
Retained Earnings / Accumulated Deficit-517.69
Other Equity0.26
Common Stockholder's Equity1,006.52
Total Stockholder's Equity1,006.52
Liabilities & Stockholder's Equity1,025.08
4 historic quarters locked

Sign in to unlock the full Terns Pharmaceuticals Inc balance sheet history.

About Terns Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-103124

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.